Fundraising FoxDCVC Bio — 2024 Investments
2 investments dated 2024 · listed companies and verified rows first · show all
Elo develops plant-based food ingredients and technologies to enhance nutritional value, taste, and climate resilience in everyday foods.
AgTechBiotechClimate TechFoodTechNew MaterialsDurham, US
ToddMichele Fite(Executive Officer)inMatthew Todd Rands(Executive Officer, Director)Chloe Pavely(Executive Officer)inMatt DiLeo(Director)inPaul Boyer(Executive Officer)in
Board seatKiersten Stead· per SEC Form D
Co-investorsDCVC (Data Collective)Accelr8KdT VenturesNovo Holdings
nChroma Bio develops in vivo targeted delivery and genetic engineering technologies for genetic medicine applications.
BiotechDeep TechMedical DevicesBoston, US
Luke Gilbert, PhD(Founder)Keith Joung, MD, PhD(Founder)David Liu, PhD(Founder)Angelo Lombardo, PhD(Founder)Luigi Naldini, MD, PhD(Founder)Jonathan Weissman, PhD
Co-investorsAtlas VentureNewpath Partners5AM VenturesARCH Venture PartnersDCVC (Data Collective)F-Prime Capital+11 more
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.